Pregabalin may increase the risk of death when coprescribed with opioids
1. Patients coprescribed opioids and pregabalin had significantly increased odds of opioid-related death compared to opioid prescription alone.
2. More than half of Ontario residents who take pregabalin are already prescribed opioids.
Study Rundown: Pregabalin is an anticonvulsant that is increasingly prescribed as an adjunct for chronic pain, often of a neuropathic nature. Many patients taking pregabalin for pain management are also prescribed opioids. This situation raises concerns, as both medications can result in CNS depression. The authors of this study published a brief research report to examine the relationship between pregabalin and opioids, considering that these medications are often prescribed concurrently. Specifically, they found an association between pregabalin and an increased risk for opioid-related death when coprescribed. One limitation of this study was that it only included patients from Ontario and may therefore not be applicable to other patient populations. However, the results are significant and applicable due to the large cohort. Overall, the results of the study highlighted the importance of considering revision to the pregabalin product monograph, which does not currently warn about the risk for serious adverse events when coprescribed with opioids.
In-Depth [case-control]: The authors conducted a nested case-control study to evaluate the risk of opioid-related death in patients that are co-prescribed opioids and pregabalin. A cohort of patients aged 15 to 105 years who received publicly funded opioids prescriptions were identified for inclusion in the study (ranging from 1997 to 2016). The case patients consisted of those who died of an opioid-related cause and was matched to up to 4 control participants. A total of 1417 case patients were ultimately matched to 5097 control participants. Exposure to pregabalin in the preceding 120 days was found to have significantly increased odds of opioid-related death (adjusted odds ratio [aOR], 1.68 [95% CI, 1.19 to 2.36]) compared to exposure to opioids alone within the 120 days. Further, the authors examined dose-response and found the higher dose of pregabalin to be associated with greater risk for opioid-related death.
©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.
Next Article in Pain
Neurology Advisor Articles
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL
- Congress Passes Bill to Fight Opioid Crisis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure